Adeshwar Meditex Limited has submitted Annual Report along with the annexures pertaining to FY 2025-26.

ADESHWAR MEDITEX LIMITED ANNUAL REPORT 2025-26 CIN: L52390MH2007PLC169544 ANNUAL REPORT 2025-2026 ADESHWAR MEDITEX LIMITED ANNUAL REPORT 2025-26 INDEX Sr. Content Page No. 1 General Information 3 2 Management Note 4 3 Notice of Annual General Meeting 6 4 Boards Report for FY 2025-26 26 5 Management Discussion and Analysis 41 (Annexure I) 6 Nomination and Remuneration Policy 45 (Annexure II) 7 Particulars of Remuneration (Annexure 53 III) 8 Particulars of Remuneration (Top 10) 55 (Annexure IV) 9 Secretarial Audit Report (Annexure V) 57 10 Independent Auditor’s Report 61 11 Financial Statements 76 ADESHWAR MEDITEX LIMITED ANNUAL REPORT 2025-26 GENERAL INFORMATION Board of Directors: Managing Director Mrs. Ashalata Baburao Raut Whole-Time Director & Chairman Mr. Krishnojirao Nagaraja Rao Mr. Abhinandan Nagaraja Rao Executive Director Mr. Shailesh Vinayak Rajpure Non-Executive, Independent Directors Mr. Benegal Parameshwara Udpa (deceased on October22, 2025) Mr. Arun Koli (resigned w.e.f. April 28, 2026) Mr. Raghupathy K Bhat (appointed w.e.f. December 20, 2025) Ms. Bhagyalaxmi Kavital (appointed w.e.f. May 21, 2026) Non-Executive Directors Mr. Prithvi Sanjay Singh (resigned w.e.f August 26, 2026) Mr. Satish Chudekar (appointed w.e.f. September 25, 2025) (resigned w.e.f August 03, 2026) Executive Management: Chief Financial Officer: Mr. Prashant Laxman Rane Company Secretary & Compliance Officer Mr. Vishal Jain Statutory Auditors M/s. Rajesh H Gupta & CO. Chartered Accountant Secretarial Auditor M/s. Deep Shukla & Associates Company Secretaries Internal Auditor M/s. Basude Makote & Saini, Chartered Accountants Bankers Union Bank of India, Bhat Bazaar Registered Office Gala 111 Lok Centre, Marol Maroshi Road, Andheri East, Marol Naka, Mumbai- 400059, Maharashtra, India. (changed w.e.f. January 03, 2024) Phone: 022-22674137/38 E-Mail:- adeshwarmedi@gmail.com/ cs.adeshwarmeditexltd@gmail.com Website: www.adeshwarmeditex.com Factory 17/18, Biwan & Sons, Udyog Nagar, Palghar West, Palghar- 401404 Registrar and Share Transfer Agent M/s. Bigshare Services Private Limited Office No S6-2, 6th Floor, Pinnacle Business Park, Next to Ahura Centre, Mahakali Caves Road, Andheri (East) Mumbai – 400093 Phone: 022 – 62638200, FAX: 022 – 62638299 E-mail:- info@bigshareonline.com Website: www.bigshareonline.com ADESHWAR MEDITEX LIMITED ANNUAL REPORT 2025-26 MANAGEMENT NOTE Dear Shareholders, It gives us immense pleasure to present the 19th Annual Report of Adeshwar Meditex Limited for the Financial Year 2025–26. Adeshwar Meditex Limited has built a strong legacy in the healthcare products sector, with its origins dating back to 1951, when the foundation of the business was laid through the vision and entrepreneurial efforts of Mr. Mulchand Talati. The Company was subsequently incorporated as a Private Limited Company on April 4, 2007, and thereafter converted into a Public Limited Company on March 9, 2021. The equity shares of the Company were listed on the SME Platform of BSE Limited on June 28, 2021, marking a significant milestone in the Company's growth journey. This Annual Report represents the fifth year of the Company's journey as a listed entity. Over the years, Adeshwar Meditex Limited has developed expertise as an integrated healthcare products company engaged in the manufacturing, processing, export, distribution, and supply of a wide range of medical consumables and healthcare solutions. The Company's diversified product portfolio includes sterile surgical wound dressings, advanced wound care products, medical bandages, gauzes, swabs, adhesive products, surgical disposables, infection prevention products, protective healthcare products, first aid kits, and other allied healthcare solutions catering to hospitals, medical institutions, industries, government organizations, distributors, and international markets. The global healthcare industry continued to witness steady expansion during Financial Year 2025–26, supported by increasing healthcare expenditure, ageing demographics, rising prevalence of chronic diseases, greater focus on infection prevention, and growing demand for quality healthcare infrastructure. The medical devices and consumables segment remains a critical component of healthcare delivery, with increasing adoption of single-use products, advanced wound care solutions, and infection control products across healthcare systems worldwide. The medical devices sector in India continued to emerge as one of the fastest-growing segments within healthcare. According to industry estimates, India's medical devices market, valued at approximately US$ 15 billion in 2025, is projected to grow significantly and reach approximately US$ 50 billion by 2030, supported by increasing healthcare demand, expansion of healthcare infrastructure, technological advancements, and policy support. India is currently among the largest medical device markets in Asia and continues to strengthen its position as a global manufacturing and export hub. The Government of India continues to promote the domestic medical device ecosystem through initiatives such as the National Medical Devices Policy, 2023, the Production Linked Incentive ADESHWAR MEDITEX LIMITED ANNUAL REPORT 2025-26 (PLI) Scheme for Medical Devices, and development of medical device parks, with the objective of enhancing domestic manufacturing capabilities, reducing import dependency, encouraging innovation, and strengthening India's global competitiveness. The healthcare sector received continued policy support, with the Union Budget 2025–26 allocating approximately ₹99,858 crore towards the healthcare sector, reflecting the Government's focus on improving healthcare infrastructure and accessibility. The Indian medical device industry also witnessed encouraging export momentum. India's medical device exports have continued to grow, supported by improving manufacturing capabilities, regulatory alignment, and increasing global acceptance of Indian healthcare products. The sector presents significant opportunities for manufacturers of medical consumables, surgical products, wound care solutions, and infection prevention products. Your Company operates in a segment that is aligned with the long-term growth drivers of the healthcare industry. With its established manufacturing capabilities, diversified product portfolio, focus on quality, and experience in serving varied healthcare requirements, Adeshwar Meditex Limited is well positioned to participate in the growth opportunities emerging in the medical disposables and healthcare products sector. The Company continues to focus on strengthening operational efficiencies, enhancing product quality, expanding its customer base, exploring export opportunities, and developing innovative healthcare solutions. The management remains committed to sustainable growth through prudent financial management, effective resource utilization, regulatory compliance, and continuous improvement across business functions. During the year under review, the Company continued to maintain high standards of corporate governance, ethical business practices, and statutory compliance. The management remains focused on creating long-term value for shareholders while contributing towards the healthcare ecosystem through reliable and quality healthcare products. On behalf of the Company, we express our sincere gratitude to our shareholders, customers, employees, suppliers, bankers, auditors, regulatory authorities, and all other stakeholders for their continued trust, confidence, and support. With a strong foundation, experienced leadership, dedicated workforce, and favourable industry outlook, we remain confident of strengthening Adeshwar Meditex Limited's position as a trusted healthcare products company and creating sustainable value for all stakeholders. STAY HEALTHY AND HAPPY! ADESHWAR MEDITEX LIMITED ANNUAL REPORT 2025-26 NOTICE NOTICE is hereby given that the 19th Annual General Meeting of [Showing first 8,000 characters — download PDF for full document]